ciprofloxacin has been researched along with thiophenes in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Bovio, C; Braga, PC; Culici, M; Dal, SM | 1 |
Emami, S; Foroumadi, A; Karimollah, A; Moshafi, MH; Oboudiat, M; Saghaee, L; Shafiee, A | 1 |
Bouhours, P; Broussous, S; David, E; Fournier Dit Chabert, J; Joucla, L; Lemaire, M; Marquet, B; Marquez, B; Moreau, N; Neville, L; Pellet-Rostaing, S | 1 |
Bhattacharjee, G; Kumar, A; Tomar, V | 1 |
Esrafilzadeh, D; Moulton, SE; Razal, JM; Stewart, EM; Wallace, GG | 1 |
Altena, R; de Wit, H; Folkeringa, R; Hoogendoorn, M; van Roon, E | 1 |
Qu, K; Rehman, A; Zeng, X | 1 |
Gao, J; Wang, Z; Zhang, CY | 1 |
Caputo, GA; Carone, BR; Ergene, C; Lee, JY; Palermo, EF; Shirley, DJ; Zhou, Z | 1 |
Barnwal, RP; De Rosa, M; Pandey, A; Sharma, A; Singh, G; Singla, N | 1 |
10 other study(ies) available for ciprofloxacin and thiophenes
Article | Year |
---|---|
The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone.
Topics: Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Drug Synergism; Epithelial Cells; Escherichia coli; Expectorants; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Staphylococcus aureus; Thioglycolates; Thiophenes | 2002 |
Synthesis and antibacterial activity of N-[2-[5-(methylthio)thiophen-2-yl]-2-oxoethyl] and N-[2-[5-(methylthio)thiophen-2-yl]-2-(oxyimino)ethyl]piperazinylquinolone derivatives.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Quinolones; Staphylococcus; Thiophenes | 2006 |
Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Cell Line, Tumor; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Ethidium; Humans; Indicators and Reagents; Macrolides; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes | 2007 |
Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Benzaldehydes; Candida; Candida albicans; Chalcones; Ciprofloxacin; Escherichia coli; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Piperazines; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes | 2007 |
Multifunctional conducting fibres with electrically controlled release of ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Electric Conductivity; Escherichia coli; Escherichia coli Infections; Humans; Polymers; Polystyrenes; Pyrroles; Streptococcal Infections; Streptococcus pyogenes; Thiophenes | 2013 |
Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring.
Topics: Aged; Antibiotics, Antitubercular; Anticoagulants; Atrial Fibrillation; Ciprofloxacin; Coronary Artery Bypass; Drug Incompatibility; Female; Humans; Morpholines; Rifampin; Rivaroxaban; Thiophenes | 2014 |
Glycosylated Conductive Polymer: A Multimodal Biointerface for Studying Carbohydrate-Protein Interactions.
Topics: Aniline Compounds; Anti-Bacterial Agents; Biosensing Techniques; Carbohydrates; Ceftriaxone; Ciprofloxacin; Electric Conductivity; Electrochemical Techniques; Glycosylation; Hydrogen-Ion Concentration; Mannosides; Microbial Sensitivity Tests; Oxidation-Reduction; Polymers; Proteins; Tetracycline; Thiophenes | 2016 |
Bioresponsive Nanoparticles Targeted to Infectious Microenvironments for Sepsis Management.
Topics: Amides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Proteins; Ciprofloxacin; Disease Models, Animal; Drug Delivery Systems; Drug Design; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Lung Diseases; Mice; Micelles; Nanoparticles; Peritonitis; Polymers; Proof of Concept Study; Sepsis; Thiophenes | 2018 |
Sequence and Dispersity Are Determinants of Photodynamic Antibacterial Activity Exerted by Peptidomimetic Oligo(thiophene)s.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; HeLa Cells; Humans; Light; Peptidomimetics; Photochemotherapy; Sheep; Staphylococcal Infections; Staphylococcus aureus; Thiophenes | 2019 |
Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains.
Topics: Antitubercular Agents; Ciprofloxacin; Disease Progression; Drug Carriers; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Structure-Activity Relationship; Thiophenes; Toll-Like Receptors | 2021 |